Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Evidence suggests that Toll-like receptor 4 (TLR4) contributes to immune recognition of respiratory syncytial virus (RSV). The TLR4 gene harbours a polymorphism-Asp299Gly-previously associated with reduced TLR4 signalling. To understand of how host genetic variation influences the outcome of RSV infection in children, we examined the association between the TLR4 299Gly allele and severe RSV disease. By genotyping 236 children with RSV infection and 219 healthy controls we found no association between the risk of severe RSV infection and Asp299Gly polymorphisms (P>0.05), and we demonstrate that the TLR4 Asp299Gly genotype does not influence susceptibility to either RSV serotype A or B (P>0.05). Finally, examining the functional impact of the TLR4 Asp299Gly polymorphism (n=58), we demonstrate that proinflammatory cytokine production following TLR4 activation was indistinguishable between homozygous (Asp/Asp) and heterozygous (Asp/Gly) subjects. We conclude that the Asp299Gly TLR4 polymorphism does not alter receptor function and does not influence the risk of severe RSV infection.

More information Original publication

DOI

10.1016/j.clim.2007.03.003

Type

Journal article

Publication Date

2007-06-01T00:00:00+00:00

Volume

123

Pages

252 - 257

Total pages

5

Keywords

Adolescent, Child, Child, Preschool, Female, Gene Frequency, Genetic Predisposition to Disease, Genotype, Humans, Infant, Infant, Newborn, Interleukin-1beta, Interleukin-6, Leukocytes, Mononuclear, Lipopolysaccharides, Male, Polymorphism, Single Nucleotide, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, Risk Factors, Toll-Like Receptor 4, Tumor Necrosis Factor-alpha